Patents by Inventor Joachim Neuwinger

Joachim Neuwinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy
    Publication number: 20040167111
    Abstract: The pharmaceutical preparations for treating side effects, such as hot flashes, prostate enlargement and gynecomastia, during and/or after treatment with analogs or antagonists of gonadotropin-releasing hormone (GnRHa therapy) contain an effective amount of a chemically modified derivative of 17&agr;-estradiol, a chemically modified derivative of 17&bgr;-estradiol and/or a chemical modified derivative of estriol. Pharmaceutical preparations containing estra 1,3,5(10)-triene-3,17&bgr;-diol-17-valerate as the effective ingredient are particularly preferred.
    Type: Application
    Filed: December 5, 2003
    Publication date: August 26, 2004
    Inventors: Michael Oettel, Ludwig Wild, Peter Licht, Joachim Neuwinger, Wolfgang Hummel, Ralph Dittrich
  • Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy
    Patent number: 6689768
    Abstract: The pharmaceutical preparations for treating side effects, such as hot flashes, prostate enlargement and gynecomastia, during and/or after treatment with analogs or antagonists of gonadotropin-releasing hormone (GnRHa therapy) contain an effective amount of a chemically modified derivative of 17&agr;-estradiol, a chemically modified derivative of 17&bgr;-estradiol and/or a chemical modified derivative of estriol. Pharmaceutical preparations containing 14&agr;, 15&agr;-methylene-1,3,5(10),8-tetraene-3,17&agr;-diol are particularly preferred.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: February 10, 2004
    Assignee: Jenapharm GmbH & Co. KG
    Inventors: Mcihael Oettel, Ludwig Wildt, Peter Licht, Joachim Neuwinger, Wolfgang Hummel, Ralph Dittrich
  • Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy
    Publication number: 20020065260
    Abstract: The pharmaceutical preparations for treating side effects, such as hot flashes, prostate enlargement and gynecomastia, during and/or after treatment with analogs or antagonists of gonadotropin-releasing hormone (GnRHa therapy) contain an effective amount of a chemically modified derivative of 17&agr;-estradiol, a chemically modified derivative of 17&bgr;-estradiol and/or a chemical modified derivative of estriol. Pharmaceutical preparations containing 14&agr;,15&agr;-methylene-1,3,5(10),8-tetraene-3,17&agr;-diol are particularly preferred.
    Type: Application
    Filed: June 26, 2001
    Publication date: May 30, 2002
    Inventors: Mcihael Oettel, Ludwig Wildt, Peter Licht, Joachim Neuwinger, Wolfgang Hummel, Ralph Dittrich
  • PHARMACEUTICAL PREPARATIONS FOR TREATING SIDE EFFECTS DURING AND/OR AFTER GNRHA THERAPY
    Publication number: 20020002153
    Abstract: The pharmaceutical preparations for treating side effects, such as hot flashes, during and/or after treatment with analogs or antagonists of gonadotropin releasing hormone (GnRHa therapy) contain an effective amount of 17&agr;-estradiol, its chemically modified derivatives, chemically modified derivatives of 17&bgr;-estradiol or estriol.
    Type: Application
    Filed: April 14, 1999
    Publication date: January 3, 2002
    Inventors: MICHAEL OETTEL, LUDWIG WILDT, PETER LICHT, JOACHIM NEUWINGER, WOLFGANG HUMMEL, RALPH DITTRICH